Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti–Acute Myeloid Leukemia Efficacy In Vitro and In Vivo-Reference-Cited by-同舟云学术

Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti–Acute Myeloid Leukemia Efficacy In Vitro and In Vivo

Published:2019-08-28 Issue:5 Volume:96 Page:589-599
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Cao Zhi-Xing,Wen Yi,He Jun-Lin,Huang Shen-Zhen,Gao Fei,Guo Chuan-Jie,Liu Qing-Qing,Zheng Shu-Wen,Gong Dao-Yin,Li Yu-Zhi,Zhang Ruo-Qi,Chen Jian-Ping,Peng Cheng

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference53 articles.

1. The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

2. Chemopreventive effects of licorice and its components;Bode;Curr Pharmacol Rep,2015

3. Synthesis and characterization of a phosphate prodrug of isoliquiritigenin;Boyapelly;J Nat Prod,2017

4. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells;Chen;Blood,1997

5. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial;Cortes;Lancet Oncol,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse;Phytomedicine;2023-12

2. Oncopreventive and Oncotherapeutic Potential of Licorice Chalcone Compounds: Molecular Insights;Mini-Reviews in Medicinal Chemistry;2023-04

3. Therapeutic Targeting of FLT3 in Acute Myeloid Leukemia: Current Status and Novel Approaches;OncoTargets and Therapy;2022-11

4. High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling;Biomedicines;2022-03-10

5. Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression;International Journal of Molecular Sciences;2022-02-28